Breaking News

Takeda Restructures After Nycomed Acquisition

Will cut global workforce by 2,800 in Europe, U.S. by 2015

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Takeda Pharmaceutical Co. Ltd. is restructuring by consolidating site operations and integrating legacy Nycomed operations. The company will align Nycomed’s former operation structures and processes with the Takeda global headquarters in Japan and the newly defined organizations of the chief commercial officer, headquartered in Zurich, Switzerland, and chief medical and scientific officer, headquartered in Deerfield, IL, and its expanded affiliate network worldwide. Takeda will consolidat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters